Javascript must be enabled to continue!
Acute effect of metformin on exercise capacity in active males
View through CrossRef
Aim: Physical activity and metformin are often used concomitantly in the treatment of diabetes, even though little is known about possible interactions between these treatment modalities. This study was designed to examine the acute effect of metformin on oxygen consumption and lactate concentration during exercise.Methods: Eleven healthy, active men [mean ± s.d.: age = 29.9 ± 3.7 years; body mass index = 25.2 ± 2.8 kg/m2; maximal oxygen consumption (VO2max) = 53.5 ± 8.9 ml/kg/min] completed a randomized, double‐blind, placebo‐controlled, crossover study. The testing protocol consisted of a standardized breakfast with metformin (1000 mg) or placebo. Three hours after breakfast, participants underwent a graded maximal exercise test on a cycle ergometer. Approximately 30 min after this exercise test, participants cycled continuously at an intensity below their ventilatory threshold for 45 min (mean exercise intensity = 69 ± 5.5% of VO2max).Results: During the graded exercise test, average oxygen consumption was higher for the metformin condition (2.9 vs. 2.8 l/min, p = 0.04); however, there was no treatment effect on VO2max or ventilatory threshold. During continuous exercise, lactate was lower for the metformin condition (4.7 vs. 5.4 mmol/l, p = 0.05). Following a standardized lunch, glucose concentrations were lower in the metformin compared with the placebo condition (5.8 vs. 6.4 mmol/l, p = 0.04).Conclusion: A single dose of metformin does not acutely influence maximal oxygen consumption or ventilatory threshold in healthy active males. The lower lactate concentration observed during continuous exercise with metformin was an unexpected finding considering that, in the resting state, metformin has been previously associated with a modest increase in lactate concentrations.
Title: Acute effect of metformin on exercise capacity in active males
Description:
Aim: Physical activity and metformin are often used concomitantly in the treatment of diabetes, even though little is known about possible interactions between these treatment modalities.
This study was designed to examine the acute effect of metformin on oxygen consumption and lactate concentration during exercise.
Methods: Eleven healthy, active men [mean ± s.
d.
: age = 29.
9 ± 3.
7 years; body mass index = 25.
2 ± 2.
8 kg/m2; maximal oxygen consumption (VO2max) = 53.
5 ± 8.
9 ml/kg/min] completed a randomized, double‐blind, placebo‐controlled, crossover study.
The testing protocol consisted of a standardized breakfast with metformin (1000 mg) or placebo.
Three hours after breakfast, participants underwent a graded maximal exercise test on a cycle ergometer.
Approximately 30 min after this exercise test, participants cycled continuously at an intensity below their ventilatory threshold for 45 min (mean exercise intensity = 69 ± 5.
5% of VO2max).
Results: During the graded exercise test, average oxygen consumption was higher for the metformin condition (2.
9 vs.
2.
8 l/min, p = 0.
04); however, there was no treatment effect on VO2max or ventilatory threshold.
During continuous exercise, lactate was lower for the metformin condition (4.
7 vs.
5.
4 mmol/l, p = 0.
05).
Following a standardized lunch, glucose concentrations were lower in the metformin compared with the placebo condition (5.
8 vs.
6.
4 mmol/l, p = 0.
04).
Conclusion: A single dose of metformin does not acutely influence maximal oxygen consumption or ventilatory threshold in healthy active males.
The lower lactate concentration observed during continuous exercise with metformin was an unexpected finding considering that, in the resting state, metformin has been previously associated with a modest increase in lactate concentrations.
Related Results
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract
BACKGROUND
Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer agent...
Abstract PO1-05-11: Efficacy of metformin as adjunctive therapy in patients with de novo metastatic breast cancer: a retrospective cohort study
Abstract PO1-05-11: Efficacy of metformin as adjunctive therapy in patients with de novo metastatic breast cancer: a retrospective cohort study
Abstract
Background: Metformin, an oral biguanide used for the treatment of type-2 diabetes mellitus (DM), has been shown in a considerable number of studies to have...
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract
Introduction and Objective. Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer age...
Metformin and Exercise in Type 2 Diabetes
Metformin and Exercise in Type 2 Diabetes
OBJECTIVE
To determine the effect of metformin on the acute metabolic response to submaximal exercise, the effect of exercise on plasma metformin concentrations, ...
PO-180 Effect of Accumulated Exercise and Continuous Exercise on Energy Metabolism
PO-180 Effect of Accumulated Exercise and Continuous Exercise on Energy Metabolism
Objective Sedentary behavior is the main feature of modern lifestyle, which relate to most chronic diseases. Therefore, it has great significance in both theory and practice of w...
PO-231 Effects of exercise on muscle atrophy in simulated weightless rats
PO-231 Effects of exercise on muscle atrophy in simulated weightless rats
Objective Insufficient physical activity, aerospace weight loss, and fixed treatment of fractures, tendons, and neuropathy, or the resulting muscle atrophy caused by reduced exerci...
Abstract 1124: Prevention of radiation-induced malignancies in Li-Fraumeni syndrome
Abstract 1124: Prevention of radiation-induced malignancies in Li-Fraumeni syndrome
Abstract
PURPOSE: Li-Fraumeni Syndrome (LFS) is a genetic disorder associated with a significant risk of early-onset cancer. This condition is driven by germline mut...
Metformin Inhibits Na+/H+ Exchanger NHE3 Resulting in Intestinal Water Loss
Metformin Inhibits Na+/H+ Exchanger NHE3 Resulting in Intestinal Water Loss
Glycemic control is the key to the management of type 2 diabetes. Metformin is an effective, widely used drug for controlling plasma glucose levels in diabetes, but it is often the...

